Latest Issue of Science News


Letters to the Editor

Letters

Statins oversold
The article that extols statins’ purported benefits for conditions ranging from infection to cancer (“Another side to statins,” SN: 5/5/12, p. 30) does not reflect the balance of evidence. Both favorable and adverse mechanisms apply. We regularly hear from patients who have suffered serious adverse effects, for whom data had not supported expectation of net benefit with statin use but who were prescribed statins by exuberant physicians influenced by the promise of benefits extolled in worshipful, imbalanced (if well-intentioned) articles like this.
Beatrice A. Golomb, Athena Hathaway Meskimen and Hindu Rao, San Diego, Calif.

Note: To comment, Science News subscribing members must now establish a separate login relationship with Disqus. Click the Disqus icon below, enter your e-mail and click “forgot password” to reset your password. You may also log into Disqus using Facebook, Twitter or Google.

X
This article is available only to subscribing members. Join SSP today or Log in.